Eads & Heald Wealth Management’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,565
Closed -$215K 131
2017
Q2
$215K Sell
1,565
-50
-3% -$6.86K 0.14% 122
2017
Q1
$221K Buy
+1,615
New +$205K 0.14% 122
2016
Q4
Sell
-1,615
Closed -$217K 133
2016
Q3
$217K Sell
1,615
-15
-0.9% -$1.99K 0.15% 123
2016
Q2
$209K Sell
1,630
-165
-9% -$20K 0.14% 124
2016
Q1
$205K Sell
1,795
-105
-6% -$11K 0.14% 126
2015
Q4
$212K Buy
+1,900
New +$205K 0.15% 126
2015
Q2
Sell
-2,325
Closed -$216K 135
2015
Q1
$216K Buy
+2,325
New +$206K 0.14% 127

Other funds holding EFX

Eads & Heald Wealth Management's EFX Position: Q3 2017 in Review

Eads & Heald Wealth Management sold out of Equifax (EFX) in Q3 2017, closing a stake of 1,565 shares — an estimated $215K sold.

Eads & Heald Wealth Management first reported a position in EFX in Q1 2015 and held it in 7 quarters. The position peaked at $221K in Q1 2017. 519 funds tracked by Wall St. Rank hold EFX as of Q3 2017.

  • Eads & Heald Wealth Management reported no remaining Equifax position as of Q3 2017 after selling out during the quarter.
  • Eads & Heald Wealth Management sold 1,565 Equifax shares in Q3 2017, an estimated $215K.
  • Eads & Heald Wealth Management first reported a position in Equifax in Q1 2015 and held it in 7 quarters.
  • Eads & Heald Wealth Management's Equifax position peaked at $221K in Q1 2017.
  • 519 funds tracked by Wall St. Rank held Equifax as of Q3 2017.

Based on Eads & Heald Wealth Management's 13F filing for Q3 2017, filed 27 Oct 2017.